Guidance Limits and Potential for Long‑term Use

Since January, one clinic in the UK has started prescribing the weight-loss medication Wegovy to 12-17 year-olds. For some, the results have been life-changing. But without evidence about the long-term impacts, is it safe?

This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestory

Guest: Roisin Kelly, commissioning editor, The Sunday Times.

Host: Manveen Rana.

Producer: Taryn Siegel.

Read more: The children taking Wegovy to turn their lives around

Further listening: Why weight loss drugs will change even more than you think

Photo: Times Media.

Get in touch: thestory@thetimes.com

This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here.

Hosted on Acast. See acast.com/privacy for more information.